After acquiring a biotech, a global pharma company faced major issues with two ongoing pharmacokinetic studies—both fully outsourced and poorly managed. Lack of CRO oversight had led to data inconsistencies, missed deadlines, and quality concerns.
Phastar was brought in to take control. By providing targeted CRO oversight, identifying critical data issues, and driving process improvements, we helped deliver an on-time database lock and restored confidence in the studies.
In the full case study, you’ll see:
- The oversight steps taken to regain control
- How we resolved data quality and reconciliation issues
- The sponsor’s feedback on Phastar’s impact
Complete the form to download the full case study.
